ErVimmune
PrivateLast Round
Series A
Jan 21, 2026
Total Funding Raised
$7.3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
ErVimmune is a biotechnology company developing therapeutic vaccines and cell therapies to treat cancers that do not respond to current immunotherapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ErVimmune Comparables
Compare ErVimmune with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hervolution Therapeutics | 88% | |
| Brenus Pharma | 82% | |
| Infinitopes Precision Immunomics | 73% |
ErVimmune Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 21, 2026 | ||||
| Grant | Nov 1, 2023 | ||||
| Seed | Jan 9, 2023 |
ErVimmune Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SPRIM Global Investments | Series A |
| EIC Accelerator | Grant |
| SPRIM Global Investments | Series A |
| Bpifrance | Seed |
| Seventure Partners | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors increased 271% MoM, reaching 899.
- Jan 21, 2026
$20M raised in Series A financing.
ErVimmune Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ErVimmune's valuation, stock price, and market status.
Is ErVimmune a public or private company?
ErVimmune is a private company.
What is the current stock price of ErVimmune?
ErVimmune is a private company with no public stock price. No recent secondary market data is available.
How much is ErVimmune worth (valuation)?
Valuation information for ErVimmune is not publicly available.
Can I buy ErVimmune stock?
ErVimmune shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ErVimmune's last funding round?
ErVimmune's most recent funding round was Series A on January 21, 2026.
Who are the main investors in ErVimmune?
Key investors in ErVimmune include SPRIM Global Investments, EIC Accelerator, SPRIM Global Investments, Bpifrance, Seventure Partners.
Will ErVimmune IPO soon?
No public IPO plans have been announced for ErVimmune.
How can I track ErVimmune secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ErVimmune's secondary market activity and sign up for updates.